This article is an erratum on:
Advances in application of CRISPR-Cas13a system
An Erratum on
Advances in application of CRISPR-Cas13a system
by Zhang L, Li S, Li R, Qiu X, Fan T, Wang B, Zhang B and Zhang Y (2024) Front. Cell. Infect. Microbiol. 14:1291557. doi: 10.3389/fcimb.2024.1291557
Due to a production error, the positions of Li Zhang and Yue Zhang were misplaced in the author list, which should be as follows:
Yue Zhang1†, Shengjun Li2†, Rongrong Li3, Xu Qiu1, Tianyu Fan4, Bin Wang1, Bei Zhang1 and Li Zhang1*.
The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: CRISPR-Cas system, CRISPR-Cas13a, genome editing, molecular diagnosis, gene therapy
Citation: Frontiers Production Office (2024) Erratum: Advances in application of CRISPR-Cas13a system. Front. Cell. Infect. Microbiol. 14:1393044. doi: 10.3389/fcimb.2024.1393044
Received: 28 February 2024; Accepted: 28 February 2024;
Published: 08 March 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, production.office@frontiersin.org